methyl 3-(8,13-diethyl-3,7,12,17,20-pentamethylporphyrin-2-yl)propanoate (33719-66-3)

Identification
Name:	methyl 3-(8,13-diethyl-3,7,12,17,20-pentamethylporphyrin-2-yl)propanoate
CAS:	33719-66-3
Molecular Formula:	C₃₃H₃₈N₄O₂
Molecular Weight:	522.6804
InChI:	InChI=1/C33H38N4O2/c1-9-22-19(5)28-16-31-23(10-2)18(4)27(35-31)15-29-20(6)24(11-12-32(38)39-8)33(37-29)21(7)26-13-17(3)25(34-26)14-30(22)36-28/h13-16,35-36H,9-12H2,1-8H3/b25-14-,26-21-,27-15-,28-16-,29-15-,30-14-,31-16-,33-21-
Molecular Structure:
Properties
Flash Point:	546.7°C
Boiling Point:	980.4°C at 760 mmHg
Density:	1.157g/cm³
Refractive index:	1.597
Flash Point:	546.7°C
Safety Data

Other Product

methyl 20-hydroxy-12-methoxy-13-[(19E)-17-methoxy-17-oxovobasan-3-yl]ibogamine-18-carboxylate
methyl (2alpha,20R)-20-hydroxy-12-methoxy-13-[(3alpha,5alpha,19E)-17-methoxy-17-oxovobasan-3-yl]ibogamine-18-carboxylate
Ibogamine-18-carboxylic acid,12-[(3R)-16-(hydroxymethyl)-17- methoxy-17-oxovobasan-3-yl]-13-methoxy- 20-oxo-,methyl ester
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
1/C15H16N2O3/c1-10-5-3-4-6-13(10)19-9-12-8-17-11(2)7-14(18)16-15(17)20-12/h3-7,12H,8-9H2,1-2H
Ibogamine-18-carboxylic acid,12-[(3R,20â)-19,20-dihydro-17- methoxy-17-oxovobasan-3-yl]-13-methoxy- 19-(2-oxopropyl)-,methyl ester,(19R)-
1/C17H22N6/c1-2-8-19-13-11-14(23-10-9-18-12-23)20-16-15(13)21-17(22-16)6-4-3-5-7-17/h9-12,19H,2-8H2,1H
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
1/C20H20N2/c1-4-10-16(11-5-1)18-19(17-12-6-2-7-13-17)22-20(21-18)14-8-3-9-15-20/h1-2,4-7,10-13H,3,8-9,14-15H
1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
(3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl) 2-[[2-chloroethyl(nitroso)carbamoyl]amino]propanoate
1/C16H14ClNO3/c1-10-6-12(17)7-11(15(10)19)8-18-9-21-16(20)13-4-2-3-5-14(13)18/h2-7,19H,8-9H2,1H
1/C18H19NO4/c1-22-15-8-11-10(7-13(15)20)5-12-16-9(3-4-19-12)6-14(21)18(23-2)17(11)16/h6-8,12,19-21H,3-5H2,1-2H
1/C17H16N2O3/c1-9(20)12-8-14-15-11(6-7-19(14)17(22)16(12)21)10-4-2-3-5-13(10)18-15/h2-5,8-9,18,20-21H,6-7H2,1H
1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
Ibogamine-18-carboxylic acid,20-hydroxy-12-[(3R)-16-(hydroxymethyl)- 17-methoxy-17-oxovobasan-3-yl]- 13-methoxy-,methyl ester,(20S)-
Dispiro[cyclopropane-1,6'(17'H)-cyclopropa[15,16]cyclopenta[a]phenanthrene-17',2''(5''H)-furan]-3',5''(2'H)-dione,1',3'',4'',7',8',9',10',11',12',13',14',15',16',20'-tetradecahydro-10',13'-dimethyl-,(2''S,8'R,9'S,10'R,13'S,14'R,15'S,16'S)-
1/C14H13N7O/c1-8-12(21-14(17)18-19-20-21)11(9-5-3-2-4-6-9)10(7-15)13(16)22-8/h2-6,11H,16H2,1H3,(H2,17,18,20
1/C15H18O2/c1-11(16)6-7-12-4-3-5-13-10-14(17-2)8-9-15(12)13/h4,8-10H,3,5-7H2,1-2H
10',13'-dimethyl-17'-(6-methylheptan-2-yl)-1',7',8',9',10',11',12',13',14',15',16',17'-dodecahydrospiro[cyclopentane-1,4'-cyclopenta[a]phenanthren]-3'(2'H)-one